Your browser doesn't support javascript.
loading
Engineering Native and Synthetic Pathways in Pseudomonas putida for the Production of Tailored Polyhydroxyalkanoates.
Mezzina, Mariela P; Manoli, María Tsampika; Prieto, M Auxiliadora; Nikel, Pablo I.
Afiliación
  • Mezzina MP; Systems Environmental Microbiology Group, The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs Lyngby, 2800, Denmark.
  • Manoli MT; Microbial and Plant Biotechnology Department, Centro de Investigaciones Biológicas «Margarita Salas¼ (CIB-CSIC), Polymer Biotechnology Group, Madrid, 28040, Spain.
  • Prieto MA; Spanish National Research Council (SusPlast-CSIC), Interdisciplinary Platform for Sustainable Plastics Toward a Circular Economy, Madrid, 28040, Spain.
  • Nikel PI; Microbial and Plant Biotechnology Department, Centro de Investigaciones Biológicas «Margarita Salas¼ (CIB-CSIC), Polymer Biotechnology Group, Madrid, 28040, Spain.
Biotechnol J ; 16(3): e2000165, 2021 Mar.
Article en En | MEDLINE | ID: mdl-33085217
ABSTRACT
Growing environmental concern sparks renewed interest in the sustainable production of (bio)materials that can replace oil-derived goods. Polyhydroxyalkanoates (PHAs) are isotactic polymers that play a critical role in the central metabolism of producer bacteria, as they act as dynamic reservoirs of carbon and reducing equivalents. PHAs continue to attract industrial attention as a starting point toward renewable, biodegradable, biocompatible, and versatile thermoplastic and elastomeric materials. Pseudomonas species have been known for long as efficient biopolymer producers, especially for medium-chain-length PHAs. The surge of synthetic biology and metabolic engineering approaches in recent years offers the possibility of exploiting the untapped potential of Pseudomonas cell factories for the production of tailored PHAs. In this article, an overview of the metabolic and regulatory circuits that rule PHA accumulation in Pseudomonas putida is provided, and approaches leading to the biosynthesis of novel polymers (e.g., PHAs including nonbiological chemical elements in their structures) are discussed. The potential of novel PHAs to disrupt existing and future market segments is closer to realization than ever before. The review is concluded by pinpointing challenges that currently hinder the wide adoption of bio-based PHAs, and strategies toward programmable polymer biosynthesis from alternative substrates in engineered P. putida strains are proposed.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pseudomonas putida / Polihidroxialcanoatos Idioma: En Revista: Biotechnol J Asunto de la revista: BIOTECNOLOGIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pseudomonas putida / Polihidroxialcanoatos Idioma: En Revista: Biotechnol J Asunto de la revista: BIOTECNOLOGIA Año: 2021 Tipo del documento: Article